“…Underestimation of HIV risk has been reported as a significant predictor of both CAS and underutilization of HIV testing ( Golub & Gamarel, 2013 ; Stephenson, White, Darbes, Hoff, & Sullivan, 2015 ; White & Stephenson, 2016 ). HIV risk perception, particularly among young MSM, may be declining, partly due to “treatment optimism,” the awareness that antiretroviral treatments are highly effective in reducing HIV viremia ( Huebner, Rebchook, & Kegeles, 2004 ), along with the introduction of pre-exposure prophylaxis (PrEP), the use of antiretroviral medications among HIV to lower risk of HIV infection ( Chen, 2013 ; Kalichman et al, 2017 ). Studies have identified increases in condomless sex and higher rates of sexually transmitted infection among PrEP users, suggesting a potential association between prevention optimism and risk compensation related to PrEP ( Holt & Murphy, 2017 ; Traeger et al, 2018 ).…”